The US government suspends cardiac stem cell research because of Harvard Universitys expert paper fraud.

category:Internet click:211
 The US government suspends cardiac stem cell research because of Harvard Universitys expert paper fraud.


BEIJING, Oct. 30 (Reporter Liu Xia) According to the British Nature magazine official website reported 29, Harvard University cardiologist Piero Anveza suspected of false papers in the dust when the United States National Heart, Lung and Blood Institute (NHLBI) suspended the use of stem cells for treatment of heart failure The clinical trial was exhausted because some had previously questioned the validity and validity of the scientific principles behind the trial.

In a statement released on the 29th, the Institute said, For prudence, cardiac stem cell research should be stopped to ensure that the study continues to meet the highest standards of safety and scientific integrity of participants.

The experiment was based on research by Anveza, who also worked at the New York Medical School in 2002, and colleagues suggested that a stem cell in the heart, called c-kit cells, could regenerate damaged hearts. The NHLBI trial, which provides a combination of c-kit cells or c-kit cells and bone marrow stem cells for patients with chronic heart failure, was launched in 2015 and aims to recruit 144 participants. So far, 125 patients have signed up.

In fact, as early as this century, because other researchers could not repeat the results of Anvezas research, some people began to question the existence of heart stem cells, but also to question the Anveza study.

Anvesa went to Harvard Medical School in 2007 and Bryan Womens Hospital in Boston, Massachusetts, but closed his laboratory in 2015. In 2017, the Partners Health Care System, the administrator of the Bremen Womens Hospital, paid $10 million to the U.S. government to settle allegations that the Anvisa team had submitted fraudulent data to obtain federal funds.

Earlier this month, Bremen Womens Hospital and Harvard University called on journal editors to withdraw 31 papers on heart stem cell research from Anveza because the survey found that the data they submitted contained manipulated or falsified data. This news immediately aroused great earthquake in academia.

Until the official website of the journal Nature, there was no contact with ANN viza for comment.

Editor in chief

The pioneers of a field turned out to be cheats; papers published in top academic journals turned out to be fakes; heart stem cells, which had been placed in great hope, turned out to be empty. The withdrawal of Anvezas paper, like the fallen domino, is the most realistic question of what to do with heart stem cell research. The answer given by the US government is pause. Ironically, so much resources are invested in this direction, consuming money, the youth of the researchers involved, and the possibilities of finding new and effective therapies. This reminds the scientific community once again that repeatable is a hard lever, and if you ignore it, the lesson is too painful. Source: ScienceDaily daily - editor in charge of China Science and Technology Net: Qiao Jun Jing _NBJ11279

The pioneers of a field turned out to be cheats; papers published in top academic journals turned out to be fakes; heart stem cells, which had been placed in great hope, turned out to be empty. The withdrawal of Anvezas paper, like the fallen domino, is the most realistic question of what to do with heart stem cell research. The answer given by the US government is pause. Ironically, so much resources are invested in this direction, consuming money, the youth of the researchers involved, and the possibilities of finding new and effective therapies. This reminds the scientific community once again that repeatable is a hard lever, and if you ignore it, the lesson is too painful.